Carlsmed (CARL) Invested Capital (2024 - 2026)

Carlsmed (CARL) has reported Invested Capital for 3 consecutive years, with $99.6 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Invested Capital rose 247.29% year-over-year to $99.6 million; the trailing twelve-month figure through Jun 2026 stood at $99.6 million (up 247.29% YoY), and the FY2025 full-year result was $114.2 million, up 306.85% from the prior year.
• Invested Capital declined to $99.6 million in Q2 2026 per CARL's latest filing, from $107.6 million in the prior quarter.
• Across five years, Invested Capital topped out at $122.1 million in Q3 2025 and bottomed at -$67.6 million in Q2 2025.
• Historically, Invested Capital has averaged $53.4 million across 3 years, with a median of $103.6 million in 2026.
• The sharpest annual moves came in 2025 and 2026: Invested Capital soared 306.85% in 2025, then jumped 247.29% in 2026.
• Over 3 years, Invested Capital stood at -$55.2 million in 2024, then soared by 306.85% to $114.2 million in 2025, then decreased by 12.77% to $99.6 million in 2026.
• According to Business Quant data, Invested Capital over the past three periods registered $99.6 million, $107.6 million, and $114.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.